Actavis, Inc., Warner Chilcott plc - M&A Call
Mon, May 20
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
-
-
-
-
-
PR Newswire (May 14, 2013)
-
PR Newswire (May 13, 2013)
-
-
PR Newswire (May 13, 2013)
-
PR Newswire (May 10, 2013)
-
PR Newswire (May 9, 2013)
-
-
PR Newswire (May 7, 2013)
-
PR Newswire (May 3, 2013)
-
PR Newswire (May 2, 2013)
-
PR Newswire (May 1, 2013)
To learn more about Seeking Alpha Pro, click here.
-
-
Watson Is Still Strong Despite A Slowing Generic Drug MarketFreedonia Freelance • Tue, Dec 11, 2012 -
-
-
-
-
Watson Pharmaceuticals: Earnings PreviewZacks Investment Research • Tue, Jul 24, 2012 -
-
-
-
-
Accretive Acquisitions Likely For Watson PharmaceuticalsTakeover Analyst • Sun, Oct 9, 2011
-
Watson Benefits From New PartnershipsJim Van Meerten • Wed, Jun 22, 2011
-
Watson Pharmaceuticals Earnings PreviewZacks Investment Research • Tue, Apr 26, 2011
-
Watson Pharmaceuticals: In-Depth Analysis for the December 2010 QuarterNeil Carvin • Sun, Feb 20, 2011 -
Watson Pharmaceuticals: Looking Ahead to December 2010 Quarterly ResultsNeil Carvin • Fri, Dec 31, 2010
-
Watson Investors Come Out Losers in CEO SubpoenaPharmalot • Mon, Dec 6, 2010 -
-
Watson Gets a Bullish PrescriptionoptionMONSTER • Tue, Nov 2, 2010 -
Watson Pharmaceuticals: Looking Ahead to September 2010 Quarterly ResultsNeil Carvin • Mon, Sep 27, 2010
-
Actavis, Inc., Warner Chilcott plc - M&A CallMon, May 20
-
Watson Pharmaceuticals, Inc. - Shareholder/Analyst CallTue, Jan 24, 2012
-
Watson Pharmaceuticals Q2 2010 Earnings Call TranscriptThu, Aug 5, 2010
-
Watson Pharmaceuticals Q1 2010 Earnings Call TranscriptMon, May 10, 2010
-
Watson Pharmaceuticals, Inc. Q4 2009 Earnings Call TranscriptTue, Feb 23, 2010
-
Watson Pharmaceuticals Q3 2009 Earnings Call TranscriptWed, Nov 4, 2009
-
at MarketWatch.com (Mon, 4:38PM)
-
at MarketWatch.com (Mon, 4:33PM)
-
at CNBC.com (Mon, 4:27PM)
-
at CNBC.com (Mon, 8:48AM)
-
at MarketWatch.com (Mon, 8:46AM)
-
at Fox Business (Mon, 7:30AM)
-
at Fox Business (Mon, 7:30AM)
-
at Fox Business (Mon, 7:23AM)
-
at CNBC.com (Thu, 7:33AM)
-
PR Newswire (May 14, 2013)
-
PR Newswire (May 13, 2013)
-
PR Newswire (May 13, 2013)
-
at MarketWatch.com (May 10, 2013)
-
PR Newswire (May 10, 2013)
-
PR Newswire (May 9, 2013)
-
PR Newswire (May 7, 2013)
-
PR Newswire (May 3, 2013)
-
PR Newswire (May 2, 2013)
-
PR Newswire (May 1, 2013)
ACT vs. ETF Alternatives
Company Description
Actavis, Inc. (NYSE: ACT) is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company has global and U.S. headquarters in Parsippany, New Jersey, USA, and international headquarters in Zug,... More
